Owlet is changing the future of wearable devices
September 30, 2021
Recently, Owlet’s smart sock was used in a study of infant tachyarrhythmia, a condition where the heart beats much more rapidly than it should be for the level of exertion, reports Utah Business Magazine. Untreated and undiagnosed tachyarrhythmias can cause symptoms of heart failure, or be a symptom of a larger heart issue.
The study revealed that these events were much more common than those found in previous studies, largely due to massive amounts of data generated by the smart sock.
Often, tachyarrhythmias in infants are difficult for doctors to identify. But now, Owlet’s data is changing that.
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
